Oct 5, 2020 - Health

Bristol Myers Squibb to buy cardiovascular drug developer MyoKardia for $13.1 billion

Dan Primack, author of Pro Rata

Illustration: Sarah Grillo/Axios

Bristol Myers Squibb agreed to buy MyoKardia, a South San Francisco-based cardiovascular drug developer, for $13.1 billion in cash.

Why it matters: This illustrates the diversification downside of last year's $74 billion tie-up with Celgene, which made Bristol Myers heavily reliant on cancer therapies.

  • The deal values MyoKardia at $225 per share, representing a 61.2% premium to Friday's closing price.

The bottom line: "Bristol Myers gains mavacamten, an experimental heart disease therapy with blockbuster potential. The drug is being tested for treating obstructive hypertrophic cardiomyopathy, a disease where a heart muscle thickens and obstructs blood flow. It affects up to 200,000 people across the U.S. and Europe," reports Reuters.

Go deeper

Jonathan Swan, Mike Allen
Updated 26 mins ago - Politics & Policy

Pence to continue traveling despite aides testing positive for COVID-19

Marc Short with Pence in March. Photo: Drew Angerer/Getty Images

Marc Short, Vice President Mike Pence’s chief of staff, tested positive for the coronavirus Saturday and is quarantining, according to a White House statement.

Why it matters: Short is Pence's closest aide, and was one of the most powerful forces on the White House coronavirus task force. Pence and second lady Karen Pence tested negative for the virus on Sunday morning, according to the vice president's office.

Go deeper (1 min. read)Arrow
Axios
39 mins ago - Politics & Policy

AOC: "Extremely important" that Biden offer Bernie Sanders a Cabinet position

Rep. Alexandria Ocasio-Cortez (D-N.Y.) said on CNN's "State of the Union" Sunday that she believes it's "extremely important" that Joe Biden offer Sen. Bernie Sanders and other progressive leaders Cabinet positions if he's elected president.

The big picture: Ocasio-Cortez was pressed repeatedly on policy differences between her and the more moderate Biden, including her opposition to fracking and support for Medicare for All. She responded that it would be a "privilege" and a "luxury" to be able to lobby a Biden administration on progressive issues, insisting that the focus right now should be on winning the White House.

Go deeper (1 min. read)Arrow
Axios
1 hour ago - Health

Mark Meadows: "We are not going to control the pandemic"

White House Chief of Staff Mark Meadows defended Vice President Pence's decision to continue traveling and campaigning despite his exposure to aides who have tested positive for COVID-19, saying Sunday that Pence is exempt from CDC guidelines because he is "essential personnel."

Why it matters: CDC guidelines call for people who have been exposed to the virus to quarantine for 14 days. Meadows said on CNN's "State of the Union" that Pence will wear a mask when he travels and argued that "he's not just campaigning," pointing to the Israel-Sudan normalization agreement announced by the White House last week.

Go deeper (1 min. read)Arrow

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!